CYTOMX THERAPEUTICS I

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

21 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

18 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

11 мар 2024 15:10:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

04 мар 2024 12:12:49 Источник NetDania Notify

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

04 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

01 мар 2024 12:17:46 Источник NetDania Notify

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

28 фев 2024 10:19:37 Источник NetDania Notify

NetDania - New 12 months High: CYTOMX THERAPEUTICS INC. - COMMON STOCK

27 фев 2024 11:18:02 Источник NetDania Notify

CytomX Therapeutics to Present at Upcoming March Investor Conferences

27 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

24 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference

12 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

04 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

21 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

07 ноя 2023 15:15:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming November Investor Conferences

01 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023

31 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting

30 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference

18 окт 2023 15:30:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

05 сен 2023 15:05:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference

10 авг 2023 15:05:00 Источник Nasdaq GlobeNewswire